CD20 (Rituximab) (clone ), anti-humanchimeric Antibody
€445.00
In stock
SKU
AC-ABV11759-100
Catalog Number: AC-ABV11759-100
Size: 100 µg
Host: Human/Mouse Chimeric IgG
Applications: E
Datasheet
Request Information
Size: 100 µg
Host: Human/Mouse Chimeric IgG
Applications: E
Datasheet
Request Information
Background:
Rituximab, a chimeric monoclonal antibody targeted against the pan-B-cell marker CD20. Mechanisms of cell destruction that have been demonstrated to be activated by rituximab binding to CD20 include direct signaling of apoptosis, complement activation and antibody dependent cellular cytotoxicity. Rituximab is a mainstay in the therapy for a broad variety of B-cell malignancies.
Other Names:
MabThra
Primary Accession: NP_690605
Concentration (mg/ml): 2 mg/ml
Rituximab, a chimeric monoclonal antibody targeted against the pan-B-cell marker CD20. Mechanisms of cell destruction that have been demonstrated to be activated by rituximab binding to CD20 include direct signaling of apoptosis, complement activation and antibody dependent cellular cytotoxicity. Rituximab is a mainstay in the therapy for a broad variety of B-cell malignancies.
Other Names:
MabThra
Primary Accession: NP_690605
Concentration (mg/ml): 2 mg/ml
| Is Featured? | No |
|---|
Write Your Own Review